American Society of Hematology

Figure 2.

Outcomes by MRD status by NGS at 10−6 sensitivity at the time of CR. (A) Cumulative incidence of relapse and (B) OS. MRDpos, MRD+; MRDneg, MRD−.

Outcomes by MRD status by NGS at 10⁻⁶ sensitivity at the time of CR. (A) Cumulative incidence of relapse and (B) OS. MRD^pos, MRD⁺; MRD^neg, MRD⁻.

This Feature Is Available To Subscribers Only

Sign In or Create an Account